BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20201891)

  • 1. Extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy.
    Kehat I; Molkentin JD
    Ann N Y Acad Sci; 2010 Feb; 1188():96-102. PubMed ID: 20201891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo.
    Purcell NH; Wilkins BJ; York A; Saba-El-Leil MK; Meloche S; Robbins J; Molkentin JD
    Proc Natl Acad Sci U S A; 2007 Aug; 104(35):14074-9. PubMed ID: 17709754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy.
    Lorenz K; Schmitt JP; Schmitteckert EM; Lohse MJ
    Nat Med; 2009 Jan; 15(1):75-83. PubMed ID: 19060905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
    Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
    J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy.
    Ruppert C; Deiss K; Herrmann S; Vidal M; Oezkur M; Gorski A; Weidemann F; Lohse MJ; Lorenz K
    Proc Natl Acad Sci U S A; 2013 Apr; 110(18):7440-5. PubMed ID: 23589880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility.
    Maillet M; Purcell NH; Sargent MA; York AJ; Bueno OF; Molkentin JD
    J Biol Chem; 2008 Nov; 283(45):31246-55. PubMed ID: 18753132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice.
    Bueno OF; De Windt LJ; Tymitz KM; Witt SA; Kimball TR; Klevitsky R; Hewett TE; Jones SP; Lefer DJ; Peng CF; Kitsis RN; Molkentin JD
    EMBO J; 2000 Dec; 19(23):6341-50. PubMed ID: 11101507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growth.
    Kehat I; Davis J; Tiburcy M; Accornero F; Saba-El-Leil MK; Maillet M; York AJ; Lorenz JN; Zimmermann WH; Meloche S; Molkentin JD
    Circ Res; 2011 Jan; 108(2):176-83. PubMed ID: 21127295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activation enhances PPARα activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway.
    Meng R; Pei Z; Zhang A; Zhou Y; Cai X; Chen B; Liu G; Mai W; Wei J; Dong Y
    Arch Biochem Biophys; 2011 Jul; 511(1-2):1-7. PubMed ID: 21530483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of p21-activated kinase-1 in mice promotes isoproterenol-induced cardiac hypertrophy in association with activation of Erk1/2 and inhibition of protein phosphatase 2A.
    Taglieri DM; Monasky MM; Knezevic I; Sheehan KA; Lei M; Wang X; Chernoff J; Wolska BM; Ke Y; Solaro RJ
    J Mol Cell Cardiol; 2011 Dec; 51(6):988-96. PubMed ID: 21971074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the role of extracellular signal-regulated kinases 1 and 2 in volume overload-induced cardiac remodelling.
    Jochmann S; Elkenani M; Mohamed BA; Buchholz E; Lbik D; Binder L; Lorenz K; Shah AM; Hasenfuß G; Toischer K; Schnelle M
    ESC Heart Fail; 2019 Oct; 6(5):1015-1026. PubMed ID: 31322843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload.
    Manso AM; Li R; Monkley SJ; Cruz NM; Ong S; Lao DH; Koshman YE; Gu Y; Peterson KL; Chen J; Abel ED; Samarel AM; Critchley DR; Ross RS
    J Biol Chem; 2013 Feb; 288(6):4252-64. PubMed ID: 23266827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular signal-regulated kinase (ERK) activation preserves cardiac function in pressure overload induced hypertrophy.
    Mutlak M; Schlesinger-Laufer M; Haas T; Shofti R; Ballan N; Lewis YE; Zuler M; Zohar Y; Caspi LH; Kehat I
    Int J Cardiol; 2018 Nov; 270():204-213. PubMed ID: 29857938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulator of G-Protein Signaling 10 Negatively Regulates Cardiac Remodeling by Blocking Mitogen-Activated Protein Kinase-Extracellular Signal-Regulated Protein Kinase 1/2 Signaling.
    Miao R; Lu Y; Xing X; Li Y; Huang Z; Zhong H; Huang Y; Chen AF; Tang X; Li H; Cai J; Yuan H
    Hypertension; 2016 Jan; 67(1):86-98. PubMed ID: 26573707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy.
    Ferguson BS; Harrison BC; Jeong MY; Reid BG; Wempe MF; Wagner FF; Holson EB; McKinsey TA
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9806-11. PubMed ID: 23720316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death.
    Bueno OF; Molkentin JD
    Circ Res; 2002 Nov; 91(9):776-81. PubMed ID: 12411391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway.
    Zhang L; Yang X; Jiang G; Yu Y; Wu J; Su Y; Sun A; Zou Y; Jiang H; Ge J
    Int J Mol Med; 2019 Sep; 44(3):885-892. PubMed ID: 31524228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CREG, a new regulator of ERK1/2 in cardiac hypertrophy.
    Xu L; Liu JM; Chen LY
    J Hypertens; 2004 Aug; 22(8):1579-87. PubMed ID: 15257182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.